-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FhVnghNBYwntPleAA8yHbyU1nVaS0tfxaJsgGSQ7a6KLlsqMP4k+Y5iD8BfLLwHJ SQ8GQNBU5c0LK8tYFm5MCw== 0000904454-02-000018.txt : 20020413 0000904454-02-000018.hdr.sgml : 20020413 ACCESSION NUMBER: 0000904454-02-000018 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020122 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WELSH CARSON ANDERSON & STOWE VII LP ET AL CENTRAL INDEX KEY: 0001012089 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 320 PARK AVENUE STREET 2: SUITE 2500 CITY: NEW YORK STATE: NY ZIP: 10022 MAIL ADDRESS: STREET 1: 320 PARK AVENUE STREET 2: SUITE 2500 CITY: NEW YORK STATE: NY ZIP: 10022 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SELECT MEDICAL CORP CENTRAL INDEX KEY: 0001035688 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 232872718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-61617 FILM NUMBER: 02514282 BUSINESS ADDRESS: STREET 1: 4716 OLD GETTYSBURG RD CITY: MECHANICSBURG STATE: PA ZIP: 17055 BUSINESS PHONE: 7179721100 MAIL ADDRESS: STREET 1: 4716 OLD GETTYSBURG RD CITY: MECHANICSBURG STATE: PA ZIP: 17055 SC 13G 1 s13g_0122-2002.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )1 Select Medical Corporation ------------------------------------------------------------------ (Name of Issuer) Common Stock, $.01 par value ----------------------------------------------------------------- (Title of Class of Securities) 816196 10 9 ----------------------------------------------------------------- (CUSIP Number) April 5, 2001 ----------------------------------------------------------------- Date of Event Which Requires Filing of this Statement Check the appropriate box to designate the rule pursuant to which this Schedule is Filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - -------- 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 816196 10 9 Page 2 of 9 Pages - ----------------------------------------------------------------- 1) Name of Reporting Person Welsh, Carson, I.R.S. Identification Anderson & Stowe No. of Above Person VII, L.P. (Entities Only) - ----------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - ----------------------------------------------------------------- 3) SEC Use Only - ----------------------------------------------------------------- 4) Citizenship or Place Delaware of Organization - ----------------------------------------------------------------- Number of 5) Sole Voting 9,642,384 shares Shares Beneficially Power of Common Stock Owned by Each (including shares Reporting Person issuable upon exercise With: of warrants) ------------------------------------ 6) Shared Voting Power -0- ------------------------------------ 7) Sole Disposi- 9,642,384 shares of tive Power Common Stock (including shares issuable upon exercise of warrants) ------------------------------------ 8) Shared Dis- positive Power -0- ------------------------------------ 9) Aggregate Amount Beneficially 9,642,384 shares of Owned by Each Reporting Person Common Stock (including shares issuable upon exercise of warrants) - ----------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - ----------------------------------------------------------------- 11) Percent of Class Represented by 20.7% Amount in Row (9) - ----------------------------------------------------------------- 12) Type of Reporting Person PN CUSIP No. 816196 10 9 Page 3 of 9 Pages - ----------------------------------------------------------------- 1) Name of Reporting Person WCAS Capital I.R.S. Identification Partners III, L.P. No. of Above Person (Entities Only) - ----------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - ----------------------------------------------------------------- 3) SEC Use Only - ----------------------------------------------------------------- 4) Citizenship or Place Delaware of Organization - ----------------------------------------------------------------- Number of 5) Sole Voting 2,534,058 shares Shares Beneficially Power of Common Stock Owned by Each (including shares Reporting Person issuable upon exercise With: of warrants) ------------------------------------ 6) Shared Voting Power -0- ------------------------------------ 7) Sole Disposi- 2,534,058 shares of tive Power Common Stock (including shares issuable upon exercise of warrants) ------------------------------------ 8) Shared Dis- positive Power -0- ------------------------------------ 9) Aggregate Amount Beneficially 2,534,058 shares of Owned by Each Reporting Person Common Stock (including shares issuable upon exercise of warrants) ----------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - ----------------------------------------------------------------- 11) Percent of Class Represented by 5.5% Amount in Row (9) - ----------------------------------------------------------------- 12) Type of Reporting Person PN CUSIP No. 816196 10 9 Page 4 of 9 Pages - ----------------------------------------------------------------- 1) Name of Reporting Person WCAS Healthcare I.R.S. Identification Partners, L.P. No. of Above Person (Entities Only) - ----------------------------------------------------------------- 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] - ----------------------------------------------------------------- 3) SEC Use Only - ----------------------------------------------------------------- 4) Citizenship or Place Delaware of Organization - ----------------------------------------------------------------- Number of 5) Sole Voting 427,511 shares Shares Beneficially Power of Common Stock Owned by Each Reporting Person With: ------------------------------------ 6) Shared Voting Power -0- ------------------------------------ 7) Sole Disposi- 427,511 shares of tive Power Common Stock ------------------------------------ 8) Shared Dis- positive Power -0- ------------------------------------ 9) Aggregate Amount Beneficially 427,511 shares of Owned by Each Reporting Person Common Stock - ----------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares - ----------------------------------------------------------------- 11) Percent of Class Represented by 0.9% Amount in Row (9) - ----------------------------------------------------------------- 12) Type of Reporting Person PN CUSIP No. 816196 10 9 Page 5 of 9 Pages Schedule 13G ------------ Item 1(a) - Name of Issuer: Select Medical Corporation Item 1(b) - Address of Issuer's Principal Executive Offices: 4716 Old Gettysburg Road Mechanicsburg, PA 17055 Item 2(a) - Name of Person Filing: This statement is being filed by Welsh, Carson, Anderson & Stowe VII, L.P., a Delaware limited partnership ("WCAS VII"), WCAS Capital Partners III, L.P., a Delaware limited partnership ("WCAS CP III"), and WCAS Healthcare Partners, L.P., a Delaware limited partnership ("WCAS HP"). Item 2(b) - Address of Principal Business Office: 320 Park Avenue, Suite 2500 New York, New York 10022 Item 2(c) - Place of Organization: WCAS VII: Delaware WCAS CP III: Delaware WCAS HP: Delaware Item 2(d) - Title of Class of Securities: Common Stock, $.01 par value Item 2(e) - CUSIP Number: 816196 10 9 Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b): Not applicable. Item 4 - Ownership. (a) Amount Beneficially Owned: WCAS VII: 9,642,384 shares of Common Stock (including shares issuable upon exercise of warrants) WCAS CP III: 2,534,058 shares of Common Stock (including shares issuable upon exercise of warrants) WCAS HP: 427,511 shares of Common Stock (b) Percent of Class: CUSIP No. 816196 10 9 Page 6 of 9 Pages WCAS VII: 20.7% WCAS CP III: 5.5% WCAS HP: 0.9% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: WCAS VII: 9,642,384 shares of Common Stock (including shares issuable upon exercise of warrants) WCAS CP III: 2,534,058 shares of Common Stock (including shares issuable upon exercise of warrants) WCAS HP: 427,511 shares of Common Stock (ii) shared power to vote or to direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: WCAS VII: 9,642,384 shares of Common Stock (including shares issuable upon exercise of warrants) WCAS CP III: 2,534,058 shares of Common Stock (including shares issuable upon exercise of warrants) WCAS HP: 427,511 shares of Common Stock (iv) shared power to dispose or to direct the disposition of: -0- Item 5 - Ownership of Five Percent or Less of a Class: Not applicable. Item 6 - Ownership of More than Five Percent on Behalf of Another Person: Not applicable. Item 7 - Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Company: Not applicable. Item 8 - Identification and Classification of Members of the Group: See Exhibit 2. Item 9 - Notice of Dissolution of Group: Not applicable. Item 10 - Certification: Not applicable. CUSIP No. 816196 10 9 Page 7 of 9 Pages Signature: After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. WELSH, CARSON, ANDERSON & STOWE VII, L.P. By: WCAS VII Partners, L.P., General Partner By /s/ Jonathan M. Rather -------------------------------------- General Partner WCAS CAPITAL PARTNERS III, L.P. By: WCAS CP III Associates, L.L.C., General Partner By /s/ Jonathan M. Rather -------------------------------------- Managing Member WCAS HEALTHCARE PARTNERS, L.P. By: WCAS HP Partners, General Partner By /s/ Jonathan M. Rather ------------------------------------- Attorney-in-Fact Date: January 15, 2002 CUSIP No. 816196 10 9 Page 8 of 9 Pages EXHIBIT 1 AGREEMENT OF WELSH, CARSON, ANDERSON & STOWE VII, L.P., WCAS CAPITAL PARTNERS III, L.P. AND WCAS HEALTHCARE PARTNERS, L.P. PURSUANT TO RULE 13d-1(k) ------------------------- The undersigned hereby agree that the Information Statement on Schedule 13G to which this Agreement is annexed as Exhibit 1 is filed on behalf of each of them in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. WELSH, CARSON, ANDERSON & STOWE VII, L.P. By: WCAS VII Partners, L.P., General Partner By /s/ Jonathan M. Rather -------------------------------------- General Partner WCAS CAPITAL PARTNERS III, L.P. By: WCAS CP III Associates, L.L.C., General Partner By /s/ Jonathan M. Rather -------------------------------------- Managing Member WCAS HEALTHCARE PARTNERS, L.P. By: WCAS HP Partners, General Partner By /s/ Jonathan M. Rather ------------------------------------- Attorney-in-Fact Date: January 15, 2002 CUSIP No. 816196 10 9 Page 9 of 9 Pages EXHIBIT 2 Identification and Classification of Members of the Group --------------------------------- Welsh, Carson, Anderson & Stowe VII, L.P., WCAS Capital Partners III, L.P. and WCAS Healthcare Partners, L.P. are filing this statement on Schedule 13G as a group. Welsh, Carson, Anderson & Stowe VII, L.P. is a Delaware limited partnership. Its sole general partner is WCAS VII Partners, L.P., a Delaware limited partnership. WCAS Capital Partners III, L.P. is a Delaware limited partnership. Its sole general partner is WCAS CP III Associates, L.L.C., a Delaware limited liability company. WCAS Healthcare Partners, L.P. is a Delaware limited partnership. Its sole general partner is WCAS HP Partners, a Delaware general partnership. -----END PRIVACY-ENHANCED MESSAGE-----